Michael Doukas

2.8k citations
65 papers · 1.1k · h-index 18

Impact in

  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 10%
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies

Papers in

    • Cholangiocarcinoma and Gallbladder Cancer Studies 8
    • Esophageal Cancer Research and Treatment 7
    • Helicobacter pylori-related gastroenterology studies 3
    • Pancreatic and Hepatic Oncology Research 3

Michael Doukas

60 papers receiving 1.1k citations

Peers

Michael Doukas
Comparison fields: 5 of 90
  • Hepatology 145
  • Oncology 344
  • Surgery 325
  • Pulmonary and Respiratory Medicine 197
  • Gastroenterology 23
Replace Toru Yasutake with:
Toru Yasutake Japan
John T. Miura United States
Masataka Kikuyama Japan
Hiroki Ochiai Japan
Kirsten Utpatel Germany
Hiroyuki Yamaguchi Japan
Jae Ho Han South Korea
Tomohisa Furuhata Japan
Yosuke Shimizu Japan
Tamito Sasaki Japan
Michael Doukas relative to Toru Yasutake Japan Toru Yasutake's profile →
Citations per field
00.5×10.8×
Toru Yasutake · 1×
Citations per year

Countries citing papers authored by Michael Doukas

Since Specialization
Citations

This map shows the geographic impact of Michael Doukas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Doukas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Doukas more than expected).

Fields of papers citing papers by Michael Doukas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Doukas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Doukas. The network helps show where Michael Doukas may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Doukas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Doukas Line = papers co-authored together Michael Doukas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2018108
2 2016107
3 200498
4 202170
5 201862
6 199659
7 201752
8 202250
9 201839
10 201632
11 202028
12 201925
13 202123
14 201622
15 201521
16 199220
17 201920
18 201619
19 198417
20 201517

About Michael Doukas

Michael Doukas is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Epidemiology and Hepatology, having authored 65 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Esophageal Cancer Research and Treatment (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Gastric Cancer Management and Outcomes (4 papers), Hepatitis B Virus Studies (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Genetic factors in colorectal cancer (3 papers). The work is most often cited by research in Hepatology (145 citations), Oncology (344 citations), Surgery (325 citations), Pulmonary and Respiratory Medicine (197 citations) and Gastroenterology (23 citations). Michael Doukas has collaborated with scholars based in Netherlands, United States and Greece. Frequent co-authors include Jan N.M. IJzermans, Marco J. Bruno, Maikel P. Peppelenbosch, Casper H.J. van Eijck, Mustafa Suker, Julie Nonnekens, Dik C. van Gent, Cecile Beerens, Marion de Jong and Melissa van Kranenburg. Their work appears in journals such as HPB, Journal of Hepatology, Endoscopy, United European Gastroenterology Journal and Investigational New Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact